Clinical Trial Registration: NCT00072995.
Article first published online: 25 MAY 2013
Copyright © 2013 The Obesity Society
Volume 21, Issue 4, pages 681–689, April 2013
How to Cite
Nicklas, J. M., Sacks, F. M., Smith, S. R., LeBoff, M. S., Rood, J. C., Bray, G. A. and Ridker, P. M. (2013), Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: The Randomized POUNDS LOST trial. Obesity, 21: 681–689. doi: 10.1002/oby.20072
Disclosure: Dr. P.M. Ridker is listed as a co-inventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease. Dr. P.M. Ridker has received research funding support from Astra-Zeneca, Novartis, and Sanofi-Aventis unrelated to this project. No other relationships disclosed.
Relevant conflicts of interest/financial disclosures: Nothing to report. Full financial disclosures and author notes may be found in the online version of this article
Funding agencies: The POUNDS LOST study was supported by grants from the National Heart, Lung, and Blood Institute (HL073286) and the General Clinical Research Center, National Institutes of Health (RR-02635). Dr. J.M. Nicklas was supported by an Institutional National Research Service Award #T32AT000051 from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health.
- Issue published online: 25 MAY 2013
- Article first published online: 25 MAY 2013
- Accepted manuscript online: 18 OCT 2012 12:57PM EST
- Manuscript Accepted: 29 AUG 2012
- Manuscript Received: 6 MAR 2012
- National Heart, Lung, and Blood Institute. Grant Number: HL073286
- General Clinical Research Center
- National Institutes of Health. Grant Number: RR-02635
- Institutional National Research Service Award. Grant Number: #T32AT000051
- National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health
- 4Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511., , , et al.
- 22A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2010; 33: 2297-2303., , , et al.
- 30Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96: 92-97., , , et al.
- 32Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008; 103: 3029-3035., , , et al.Direct Link: